Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Frailty and aging
Authors
S. Sourdet
M. E. Rouge-Bugat
B. Vellas
F. Forette
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 4/2012
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-012-0040-1

Other articles of this Issue 4/2012

The journal of nutrition, health & aging 4/2012 Go to the issue

Probiotics in the Gastrointestinal Diseases of the Elderly

Probiotics in the gastrointestinal diseases of the elderly

JNHA: Clinical Neurosciences

Nutrition and vascular dementia

JNHA: Nutrition

Serum carotenoids and pulmonary function in older community-dwelling women

JNHA: Clinical Trials and Aging

Glutamine preconditioning protects against local and systemic injury induced by orthopaedic surgery

Analyses of Laboratory Data and Establishment of Reference Values and Intervals

Analyses of laboratory data and establishment of reference values and intervals for healthy elderly people

JNHA: Biology and Aging

Effects of genistein and daidzein on hippocampus neuronal cell proliferation and BDNF expression in H19-7 neural cell line

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits